Article Information
PMID
Published By
Print ISSN
0250-7005
Online ISSN
1791-7530
History
- Received August 22, 2014
- Revision received October 2, 2014
- Accepted October 8, 2014
- Published online December 30, 2014.
Copyright & Usage
Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- YOSHITARO SHINDO1,
- KIYOSHI YOSHIMURA1,5⇑,
- ATSUO KURAMASU2,
- YUSAKU WATANABE1,
- HIDEAKI ITO3,
- TOMOKO KONDO3,
- ATSUNORI OGA3,
- HIROSHI ITO3,
- SHIGEFUMI YOSHINO1,
- SHOICHI HAZAMA1,
- KOJI TAMADA4,
- HIDEO YAGITA6 and
- MASAAKI OKA1
- 1Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan
- 2Department of Molecular Pharmacology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan
- 3Department of Molecular Pathology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan
- 4Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan
- 5Division of Cancer Immunotherapy, Exploratory Oncology Research & Clinical Trial Center in Tsukiji, National Cancer Center, Chuo-ku, Tokyo, Japan
- 6Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan
- Correspondence to: Kiyoshi Yoshimura, MD, Ph.D., Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan. Tel: +81 836222264, Fax: +81 836222263, e-mail: kyoshim6705{at}gmail.com
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Combinatorial immunotherapy induces tumor-infiltrating CD8+ T cells with distinct functional, migratory, and stem-like properties
- CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models
- B7-H3x4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes
- Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity
- Protection induced by anti-PD-1 and anti-PD-L1 treatment in Leishmania amazonensis-infected BALB/c mice
- Tumor-draining lymph nodes resection and chemotherapy have diverse impacts on cancer immunotherapies
- Identifying Rational Candidates for Immunotherapy Targeting PD-1/PD-L1 in Cervical Cancer
- Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series
- Therapeutic Efficacy of 4-1BB Costimulation Is Abrogated by PD-1 Blockade in a Model of Spontaneous B-cell Lymphoma
- Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy